Citius Oncology Inc.CTORNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+33.6%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+33.6%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
2.4x
Strong expansion
Streak
4 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$18.79M+9.9%
2025$17.10M+9.3%
2024$15.65M+98.6%
2023$7.88M+175.8%
2022$2.86M-